Article
Rewiring glucose metabolism improves 5-FU efficacy in glycolytic p53-deficient colorectal tumors
2021-11-16
Abstract excerpt
5-fluorouracil (5-FU) is the backbone for chemotherapy in colorectal cancer (CRC). Response rates in patients are, however, limited to 50%. Despite the importance of 5-FU, the molecular mechanisms by which it induces toxicity remain unclear, limiting the development of strategies to improve efficacy. How fundamental aspects of cancer, such as driver mutations and phenotypic intra-tumor heterogeneity, relate to the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 820925ba-5039-5185-8f68-b25ebcec4ca3
- DOI
- 10.1101/2021.11.11.468185
